Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
UH-232, or (+)-UH-232, also known as 5-hydroxy-1-methyl-2-(dipropylamino)tetralin methyl ether (5-HMDPTME), is a dopamine and serotonin receptor modulator of the 2-aminotetralin family which was under development for the treatment of schizophrenia but was never marketed. It is taken orally. Contrary to expectations, the drug did not end up producing…
History, Applications & Research
Explore the main themes, entities and connections around UH-232. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
dopamine effects receptor serotonin d2 hallucinogenic also d3 drug schizophrenia antagonist partial 5-ht2a treatment reported agonist 2-aminotetralin receptors 5-ht2 stimulant-like
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| UH-232 | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| UH-232 | ATC code | None | 1.00 | infobox |
| UH-232 | Bioavailability | 3.7% (rats) | 1.00 | infobox |
| UH-232 | CAS Number | 95999-12-5 Y | 1.00 | infobox |
| UH-232 | ChEBI | CHEBI:114198 | 1.00 | infobox |
| UH-232 | ChEMBL | ChEMBL278751 | 1.00 | infobox |
| UH-232 | ChemSpider | 5037017 | 1.00 | infobox |
| UH-232 | CompTox Dashboard (EPA) | DTXSID70875101 | 1.00 | infobox |
| UH-232 | Drug class | Dopamine D2 receptor antagonist; Dopamine D3 receptor weak partial agonist; Serotonin 5-HT2A receptor agonist; Hallucinogen; Serotonergic psychedelic | 1.00 | infobox |
| UH-232 | Elimination half-life | 2.5 hours (rats) | 1.00 | infobox |
| UH-232 | Formula | C18H29NO | 1.00 | infobox |
| UH-232 | Metabolites | AJ-76 | 1.00 | infobox |
| UH-232 | Molar mass | 275.436 g·mol−1 | 1.00 | infobox |
| UH-232 | Other names | UH232; (+)-UH-232; (+)-UH232; (+)-cis-5-Methoxy-1-methyl-2-(dipropylamino)tetralin; 5-HMDPTME; 5-Hydroxy-1-methyl-2-(dipropylamino)tetralin methyl ether | 1.00 | infobox |
| UH-232 | PubChem CID | 6604756 | 1.00 | infobox |
| UH-232 | Routes of administration | Oral | 1.00 | infobox |
| UH-232 | UNII | QQYOR9S587 | 1.00 | infobox |
| UH-232 | is a | functional antagonist or partial agonist of the dopamine receptors in humans.In addition to the dopamine D2 and D3 receptors | 0.90 | text |
| UH-232 | is a | substituted 2-aminotetralin | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.